Search results
Biogen Inc. (NASDAQ:BIIB) Receives $286.50 Consensus Target Price from Analysts
ETF DAILY NEWS· 8 hours agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the firm, MarketBeat Ratings ...
Infusions for psoriatic arthritis: Purpose, medications, benefits
Medical News Today· 2 days agoInfusion therapy for psoriatic arthritis (PsA) involves administering medications known as biologics...
'Back to Business': Ozempic MDL's New Judge Pushes Litigation Forward in Wake of Predecessor's Death...
Law.com· 4 days agoThe judge newly reassigned to oversee the Ozempic multidistrict litigation appeared eager to stave...
With A Similar Revenue Base, Is Johnson & Johnson A Better Pick Despite The 30% Fall In Tesla Stock...
Forbes· 3 days agoIn this case, although these companies are from different sectors, they share a similar revenue base...
Cim Investment Management Inc. Trims Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 1 day agoCim Investment Management Inc. decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
Lighthouse Investment Partners LLC Invests $272,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoLighthouse Investment Partners LLC purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the 4th quarter, according to the company in its most recent Form 13F ...
Biogen Inc. (NASDAQ:BIIB) Stock Position Trimmed by Stephens Inc. AR
ETF DAILY NEWS· 6 days agoStephens Inc. AR cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange ...